Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioPorto Diagnostics AS

www.bioporto.com

Latest From BioPorto Diagnostics AS

Deals Shaping the Medical Industry, December 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2016.

Deals BioPharmaceutical

Medtech Execs On The Move, February 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

Execs On The Move, February 2015

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q1 2014

Device financing dropped more than 40% to $714 million in Q1; Smith & Nephew’s $1.7 billion acquisition of ArthroCare overshadowed acquisitions. Diagnostics companies raised $568 million, a 34% increase over 2013’s final quarter; nonprofits provided assets to diagnostics firms in multiple licensing arrangements.

Medical Device Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • BioPorto Diagnostics AS
  • Senior Management
  • Peter Morch Eriksen, CEO
    Jakob Brix Christensen, CFO
    Jan Kuhlmann Andersen, COO
  • Contact Info
  • BioPorto Diagnostics AS
    Phone: 4529 000
    Tuborg Havnevej 15, st
    Gentofte, DK-2900
    Denmark
Advertisement
Advertisement
UsernamePublicRestriction

Register